Robin J. Steele is listed as a director on 8 SEC Form D filings by 2 issuers between Jul 2017 and Aug 2026: Alveo Technologies Inc. (Alameda, CA — biotechnology — 2018–2021; $47.6M reported sold to 248 investors) and Dare Bioscience, Inc. (San Diego, CA — biotechnology — 2017–2026; $20.7M reported sold to 28 investors).
What this means 2 separate companies raised money with this person listed as director, over about 9 years. Across those companies the filings report $68.3M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Robin J. Steele and found 11 differences, 2 worth asking the sponsor about: Paid seller listed without a CRD number: Maxim Group LLC; 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.